Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

17.36
+0.18501.08%
Volume:2.88M
Turnover:49.69M
Market Cap:13.84B
PE:-15.53
High:17.51
Open:17.36
Low:16.82
Close:17.17
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:154.32M
Volume Ratio:1.01
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.98
PE(LYR):-12.02

Loading ...

Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 25, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 24, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 05, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report